Kronos Bio, Inc.
NASDAQ:KRON
0.9 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2.688 | 2.52 | 2.286 | 0.917 | 1.864 | 1.221 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.42 | 1.272 | 0.478 | 0.51 | 1.179 | 1.154 | 1.143 | 1.154 | 1.14 | 1.091 | 1.163 | 0.898 | 1.115 | 0.905 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 2.268 | 1.248 | 1.808 | 0.407 | 0.685 | 0.067 | -1.143 | -1.154 | -1.14 | -1.091 | -1.163 | -0.898 | -1.115 | -0.905 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.844 | 0.495 | 0.791 | 0.444 | 0.367 | 0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 13.345 | 13.747 | 18.226 | 25.344 | 22.673 | 19.658 | 23.168 | 23.403 | 22.706 | 24.438 | 50.819 | 24.688 | 19.802 | 17.594 | 13.125 | 16.755 | 7.175 | 6.195 | 4.748 | 3.526 | 2.586 | 2.586 |
General & Administrative Expenses
| 6.368 | 7.506 | 10.926 | 9.398 | 11.359 | 10.056 | 10.514 | 10.135 | 10.824 | 11.927 | 11.587 | 8.985 | 9.339 | 8.584 | 7.963 | 4.054 | 1.623 | 1.154 | 1.108 | 0.797 | 0.655 | 0.655 |
Selling & Marketing Expenses
| 1.216 | -0.797 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.078 | 0.078 |
SG&A
| 6.368 | 6.709 | 10.926 | 9.398 | 11.359 | 10.056 | 10.514 | 10.135 | 10.824 | 11.927 | 11.587 | 8.985 | 9.339 | 8.584 | 7.963 | 4.054 | 1.623 | 1.154 | 1.108 | 0.797 | 0.733 | 0.733 |
Other Expenses
| 0.578 | 12.786 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12.193 | -15.215 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 19.713 | 20.456 | 29.152 | 34.742 | 34.032 | 29.714 | 33.682 | 33.538 | 33.53 | 36.365 | 62.406 | 33.673 | 29.141 | 26.178 | 21.088 | 20.809 | 8.798 | 7.349 | 5.856 | 4.323 | 3.319 | 3.319 |
Operating Income
| -17.445 | -19.208 | -27.344 | -33.825 | -32.168 | -28.493 | -33.682 | -33.538 | -33.53 | -36.365 | -62.406 | -33.673 | -29.141 | -26.178 | -21.088 | -20.809 | -8.798 | -7.349 | -5.856 | -4.323 | -3.319 | -3.319 |
Operating Income Ratio
| -6.49 | -7.622 | -11.962 | -36.887 | -17.258 | -23.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 1.245 | -10.75 | 2.024 | 2.451 | 2.427 | 2.255 | 1.9 | 1.282 | 0.627 | 0.102 | 0.072 | 0.07 | 0.086 | 0.092 | -12.193 | -15.215 | 0.219 | 0.354 | 0.391 | 0.31 | -0.001 | -0.001 |
Income Before Tax
| -16.2 | -29.958 | -25.32 | -31.374 | -29.741 | -26.238 | -31.782 | -32.256 | -32.903 | -36.263 | -62.334 | -33.603 | -29.055 | -26.086 | -33.157 | -39.713 | -8.579 | -6.995 | -5.465 | -4.013 | -3.32 | -3.32 |
Income Before Tax Ratio
| -6.027 | -11.888 | -11.076 | -34.214 | -15.955 | -21.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | 1.229 | 3.334 | -0.51 | 0.457 | -2.824 | -2.629 | -1.282 | -0.627 | -0.102 | -0.474 | 0.07 | 0.086 | 0.092 | -12.493 | -11.326 | 0.219 | 0.355 | -0.311 | 0.311 | 0 | 0 |
Net Income
| -16.2 | -29.958 | -25.32 | -31.374 | -29.741 | -23.414 | -29.153 | -30.974 | -32.276 | -36.161 | -62.334 | -33.603 | -29.055 | -26.086 | -33.157 | -39.713 | -8.579 | -6.995 | -5.465 | -4.013 | -3.32 | -3.32 |
Net Income Ratio
| -6.027 | -11.888 | -11.076 | -34.214 | -15.955 | -19.176 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.27 | -0.5 | -0.43 | -0.54 | -0.52 | -0.41 | -0.52 | -0.55 | -0.58 | -0.65 | -1.13 | -0.61 | -0.53 | -0.48 | -0.7 | -0.73 | -0.17 | -0.25 | -0.19 | -0.14 | -0.69 | -0.69 |
EPS Diluted
| -0.27 | -0.5 | -0.43 | -0.54 | -0.52 | -0.41 | -0.52 | -0.55 | -0.58 | -0.65 | -1.13 | -0.61 | -0.53 | -0.48 | -0.7 | -0.73 | -0.17 | -0.25 | -0.19 | -0.14 | -0.69 | -0.69 |
EBITDA
| -17.025 | -17.936 | -26.866 | -33.825 | -31.589 | -28.493 | -33.682 | -33.538 | -32.966 | -35.808 | -62.334 | -33.08 | -28.591 | -25.642 | -33.157 | -35.628 | -8.396 | -6.834 | -6.026 | -3.922 | -3.256 | -3.256 |
EBITDA Ratio
| -6.334 | -7.117 | -11.752 | -36.887 | -16.947 | -23.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |